Romero-López Cristina, Ramos-Lorente Sara Esther, Berzal-Herranz Alfredo
Instituto de Parasitología y Biomedicina López-Neyra (IPBLN-CSIC), Av. del Conocimiento 17, 18016 Armilla, Granada, Spain.
Pharmaceuticals (Basel). 2021 Nov 20;14(11):1192. doi: 10.3390/ph14111192.
RNA viruses encode essential information in their genomes as conserved structural elements that are involved in efficient viral protein synthesis, replication, and encapsidation. These elements can also establish complex networks of RNA-RNA interactions, the so-called RNA interactome, to shape the viral genome and control different events during intracellular infection. In recent years, targeting these conserved structural elements has become a promising strategy for the development of new antiviral tools due to their sequence and structural conservation. In this context, RNA-based specific therapeutic strategies, such as the use of siRNAs have been extensively pursued to target the genome of different viruses. Importantly, siRNA-mediated targeting is not a straightforward approach and its efficiency is highly dependent on the structure of the target region. Therefore, the knowledge of the viral structure is critical for the identification of potentially good target sites. Here, we describe detailed protocols used in our laboratory for the in vitro study of the structure of viral RNA genomes. These protocols include DMS (dimethylsulfate) probing, SHAPE (selective 2'-hydroxyl acylation analyzed by primer extension) analysis, and HMX (2'-hydroxyl molecular interference). These methodologies involve the use of high-throughput analysis techniques that provide extensive information about the 3D folding of the RNA under study and the structural tuning derived from the interactome activity. They are therefore a good tool for the development of new RNA-based antiviral compounds.
RNA病毒在其基因组中编码基本信息,这些信息以保守的结构元件形式存在,参与高效的病毒蛋白合成、复制和衣壳化过程。这些元件还能建立复杂的RNA-RNA相互作用网络,即所谓的RNA相互作用组,以塑造病毒基因组并控制细胞内感染期间的不同事件。近年来,由于这些保守结构元件的序列和结构保守性,靶向它们已成为开发新型抗病毒工具的一种有前景的策略。在这种背景下,基于RNA的特异性治疗策略,如使用小干扰RNA(siRNA),已被广泛用于靶向不同病毒的基因组。重要的是,siRNA介导的靶向并非一种简单的方法,其效率高度依赖于靶区域的结构。因此,了解病毒结构对于识别潜在的良好靶位点至关重要。在这里,我们描述了我们实验室用于体外研究病毒RNA基因组结构的详细方案。这些方案包括硫酸二甲酯(DMS)探针法、选择性2'-羟基酰化引物延伸分析(SHAPE)以及2'-羟基分子干扰(HMX)。这些方法涉及使用高通量分析技术,这些技术可提供有关所研究RNA的三维折叠以及源自相互作用组活性的结构调整的广泛信息。因此,它们是开发新型基于RNA的抗病毒化合物的良好工具。